News
Founder's Story Part 2: C. elegans Preclinical Trials
2023-02-11
Watch the second half of our company presentation from the 2023 Korean C. elegans Meeting, featuring elegslab's innovative platforms for C. elegans-based preclinical trials and safety assessments.
Get a 1:1 consultation with elegslab today.
Contact us, and we’ll get back to you within 3 business days.